Aerosol drug inhibition of lung metastases
CA 2486622 A1 · Owner: Knight, J. Vernon · Inventors: Knight, J. Vernon; Waldrep, J. Clifford; Koshkina, Nadezhda
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of inhibiting growth of lung metastases in an individual comprising the steps of administering a dose of a lipid-drug enhancer liposomal complex and in sequence, administering a dose , of a lipidanticancer drug liposomal complex. Furthermore the lipid-drug , enhancer liposomal complex may be administered in a continuing dose with the lipid-anticancer drug liposomal complex whereby both liposomal complexes are mixed in the nebulizer. Methods of inhibiting growth of lung metastases in an individual by the sequential administration via aerosolization of a dilauroylphosphatidylcholine-cyclosporin A liposomal complex and a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 15, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 15, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.